Supplementary Table 1 from The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression

PDF file - 50K, Human microarray summary. Summary of correlations between ZNF217 and selected genes from ChIP-chip and gene expression microarray datasets. ZNF217 expression levels correlated with expression of K19 and K8/18, genes that have ZNF217 enriched at their promoters, in human breast cancer cell lines, tumors, and after knockdown in MCF7 cells